Skip Navigation

A Multi-national, Multi-center, Open-label, Phase II Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 Liporaxel, Oral Paclitaxel Compared to IV Paclitaxel in Patients with Recurrent or Metastatic Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03326102

Study #:
STUDY00141779

Start Date:
May 30, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03326102

View Complete Trial Details & Eligibility at ClinicalTrials.gov